BioMarin Pharmaceutical
BMRN
#1907
Rank
S$13.29 B
Marketcap
S$69.20
Share price
-0.78%
Change (1 day)
-21.86%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total assets

Total assets on the balance sheet as of September 2025 : S$9.86 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total assets are S$9.86 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioMarin Pharmaceutical - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$9.49 B5.14%
2023-12-31S$9.03 B5.72%
2022-12-31S$8.54 B5.28%
2021-12-31S$8.11 B4.93%
2020-12-31S$7.73 B22.36%
2019-12-31S$6.32 B4.55%
2018-12-31S$6.04 B-2.4%
2017-12-31S$6.19 B6.41%
2016-12-31S$5.82 B10.39%
2015-12-31S$5.27 B61.28%
2014-12-31S$3.27 B15.04%
2013-12-31S$2.84 B48.24%
2012-12-31S$1.91 B13.42%
2011-12-31S$1.69 B3.97%
2010-12-31S$1.62 B26.31%
2009-12-31S$1.28 B-0.7%
2008-12-31S$1.29 B10.53%
2007-12-31S$1.17 B65.09%
2006-12-31S$0.71 B118.54%
2005-12-31S$0.32 B-14.44%
2004-12-31S$0.38 B-12.73%
2003-12-31S$0.43 B126.91%
2002-12-31S$0.19 B-39.65%
2001-12-31S$0.31 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$1.54 B-84.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.11 B-98.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.47 B-95.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$197.39 B 1,900.35%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
S$1.12 B-88.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$1.36 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA